A citation-based method for searching scientific literature

Moshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, John P Ray, Carl G de Boer, Russell W Jenkins, David J Lieb, Jonathan H Chen, Dennie T Frederick, Michal Barzily-Rokni, Samuel S Freeman, Alexandre Reuben, Paul J Hoover, Alexandra-Chloé Villani, Elena Ivanova, Andrew Portell, Patrick H Lizotte, Amir R Aref, Jean-Pierre Eliane, Marc R Hammond, Hans Vitzthum, Shauna M Blackmon, Bo Li, Vancheswaran Gopalakrishnan, Sangeetha M Reddy, Zachary A Cooper, Cloud P Paweletz, David A Barbie, Anat Stemmer-Rachamimov, Keith T Flaherty, Jennifer A Wargo, Genevieve M Boland, Ryan J Sullivan, Gad Getz, Nir Hacohen. Cell 2018
Times Cited: 448



Hanjie Li, Anne M van der Leun, Ido Yofe, Yaniv Lubling, Dikla Gelbard-Solodkin, Alexander C J van Akkooi, Marlous van den Braber, Elisa A Rozeman, John B A G Haanen, Christian U Blank, Hugo M Horlings, Eyal David, Yael Baran, Akhiad Bercovich, Aviezer Lifshitz, Ton N Schumacher, Amos Tanay, Ido Amit. Cell 2019
Times Cited: 258




List of shared articles



Times cited

Ectopic Tcf1 expression instills a stem-like program in exhausted CD8+ T cells to enhance viral and tumor immunity.
Qiang Shan, Sheng'en Hu, Xia Chen, Derek B Danahy, Vladimir P Badovinac, Chongzhi Zang, Hai-Hui Xue. Cell Mol Immunol 2021
15

Intravenous nanoparticle vaccination generates stem-like TCF1+ neoantigen-specific CD8+ T cells.
Faezzah Baharom, Ramiro A Ramirez-Valdez, Kennedy K S Tobin, Hidehiro Yamane, Charles-Antoine Dutertre, Ahad Khalilnezhad, Glennys V Reynoso, Vincent L Coble, Geoffrey M Lynn, Matthew P Mulè,[...]. Nat Immunol 2021
14

CD147 regulates antitumor CD8+ T-cell responses to facilitate tumor-immune escape.
Yatong Chen, Jing Xu, Xiaodong Wu, Hui Yao, Zhou Yan, Ting Guo, Wenjing Wang, Peixiao Wang, Yu Li, Xiangmin Yang,[...]. Cell Mol Immunol 2021
2

BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes.
Lukas Peiffer, Farnoush Farahpour, Ashwin Sriram, Ivelina Spassova, Daniel Hoffmann, Linda Kubat, Patrizia Stoitzner, Thilo Gambichler, Antje Sucker, Selma Ugurel,[...]. Cancer Immunol Immunother 2021
1

Understanding the tumor microenvironment for effective immunotherapy.
Habib Sadeghi Rad, James Monkman, Majid E Warkiani, Rahul Ladwa, Ken O'Byrne, Nima Rezaei, Arutha Kulasinghe. Med Res Rev 2021
8

Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells.
Anthony Kusnadi, Ciro Ramírez-Suástegui, Vicente Fajardo, Serena J Chee, Benjamin J Meckiff, Hayley Simon, Emanuela Pelosi, Grégory Seumois, Ferhat Ay, Pandurangan Vijayanand,[...]. Sci Immunol 2021
34

Contribution of resident and circulating precursors to tumor-infiltrating CD8+ T cell populations in lung cancer.
Paul Gueguen, Christina Metoikidou, Thomas Dupic, Myriam Lawand, Christel Goudot, Sylvain Baulande, Sonia Lameiras, Olivier Lantz, Nicolas Girard, Agathe Seguin-Givelet,[...]. Sci Immunol 2021
4

Melanoma Single-Cell Biology in Experimental and Clinical Settings.
Hans Binder, Maria Schmidt, Henry Loeffler-Wirth, Lena Suenke Mortensen, Manfred Kunz. J Clin Med 2021
0

Melanoma models for the next generation of therapies.
E Elizabeth Patton, Kristen L Mueller, David J Adams, Niroshana Anandasabapathy, Andrew E Aplin, Corine Bertolotto, Marcus Bosenberg, Craig J Ceol, Christin E Burd, Ping Chi,[...]. Cancer Cell 2021
7

Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy.
Riyao Yang, Linlin Sun, Ching-Fei Li, Yu-Han Wang, Jun Yao, Hui Li, Meisi Yan, Wei-Chao Chang, Jung-Mao Hsu, Jong-Ho Cha,[...]. Nat Commun 2021
20

Intratumoral heterogeneity in cancer progression and response to immunotherapy.
Ilio Vitale, Efrat Shema, Sherene Loi, Lorenzo Galluzzi. Nat Med 2021
33

The current landscape of single-cell transcriptomics for cancer immunotherapy.
Puneeth Guruprasad, Yong Gu Lee, Ki Hyun Kim, Marco Ruella. J Exp Med 2021
6

Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity.
Allan Relecom, Maysaloun Merhi, Varghese Inchakalody, Shahab Uddin, Darawan Rinchai, Davide Bedognetti, Said Dermime. J Exp Clin Cancer Res 2021
0

Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment.
Xianwen Ren, Lei Zhang, Yuanyuan Zhang, Ziyi Li, Nathan Siemers, Zemin Zhang. Annu Rev Immunol 2021
6

Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment.
Rongqun Guo, Mengdie Lü, Fujiao Cao, Guanghua Wu, Fengcai Gao, Haili Pang, Yadan Li, Yinyin Zhang, Haizhou Xing, Chunyan Liang,[...]. Biomark Res 2021
3

Circulating clonally expanded T cells reflect functions of tumor-infiltrating T cells.
Liliana E Lucca, Pierre-Paul Axisa, Benjamin Lu, Brian Harnett, Shlomit Jessel, Le Zhang, Khadir Raddassi, Lin Zhang, Kelly Olino, James Clune,[...]. J Exp Med 2021
3

Progressive immune dysfunction with advancing disease stage in renal cell carcinoma.
David A Braun, Kelly Street, Kelly P Burke, David L Cookmeyer, Thomas Denize, Christina B Pedersen, Satyen H Gohil, Nicholas Schindler, Lucas Pomerance, Laure Hirsch,[...]. Cancer Cell 2021
7

EOMES is essential for antitumor activity of CD8+ T cells in chronic lymphocytic leukemia.
Laura Llaó-Cid, Philipp M Roessner, Vicente Chapaprieta, Selcen Öztürk, Tobias Roider, Marie Bordas, Ana Izcue, Dolors Colomer, Sascha Dietrich, Stephan Stilgenbauer,[...]. Leukemia 2021
2


Predicting recognition between T cell receptors and epitopes with TCRGP.
Emmi Jokinen, Jani Huuhtanen, Satu Mustjoki, Markus Heinonen, Harri Lähdesmäki. PLoS Comput Biol 2021
6

Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade.
Romain Banchereau, Avantika S Chitre, Alexis Scherl, Thomas D Wu, Namrata S Patil, Patricia de Almeida, Edward E Kadel Iii, Shravan Madireddi, Amelia Au-Yeung, Chikara Takahashi,[...]. J Immunother Cancer 2021
2